Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frida Ponthan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|May 26, 2010
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivoHelena Gleissman, Lova Segerström, Mats Hamberg, et al.
Cancer Research|October 20, 2004
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivoJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
Cancer Letters|June 25, 2005
NSAIDs in neuroblastoma therapyJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2008
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapyBaldur Sveinbjörnsson, Agnes Rasmuson, Ninib Baryawno, et al.
Cancer Letters|June 11, 2005
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitationsMagnus Lindskog, Christian Spenger, Tomas Klason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivoFrida Ponthan, Malin Wickström, Helena Gleissman, et al.
Molecular Cancer Therapeutics|September 19, 2007
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivoMalin Wickström, John Inge Johnsen, Frida Ponthan, et al.
International Journal of Cancer|March 31, 2006
The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivoLiv Tone Eliassen, Gerd Berge, Arild Leknessund, et al.
Blood|September 26, 2014
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibitionJulie Irving, Elizabeth Matheson, Lynne Minto, et al.
Cell Reports|January 12, 2017
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in LeukemiaJon Kerry, Laura Godfrey, Emmanouela Repapi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|May 26, 2010
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivoHelena Gleissman, Lova Segerström, Mats Hamberg, et al.
Cancer Research|October 20, 2004
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivoJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
Cancer Letters|June 25, 2005
NSAIDs in neuroblastoma therapyJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2008
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapyBaldur Sveinbjörnsson, Agnes Rasmuson, Ninib Baryawno, et al.
Cancer Letters|June 11, 2005
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitationsMagnus Lindskog, Christian Spenger, Tomas Klason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivoFrida Ponthan, Malin Wickström, Helena Gleissman, et al.
Molecular Cancer Therapeutics|September 19, 2007
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivoMalin Wickström, John Inge Johnsen, Frida Ponthan, et al.
International Journal of Cancer|March 31, 2006
The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivoLiv Tone Eliassen, Gerd Berge, Arild Leknessund, et al.
Blood|September 26, 2014
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibitionJulie Irving, Elizabeth Matheson, Lynne Minto, et al.
Cell Reports|January 12, 2017
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in LeukemiaJon Kerry, Laura Godfrey, Emmanouela Repapi, et al.
Pageof 3